Gouton, E.; Malissen, N.; André, N.; Jeanson, A.; Pelletier, A.; Testot-Ferry, A.; Gaudy-Marqueste, C.; Dahan, L.; Tabouret, E.; Chevalier, T.;
et al. Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer. Curr. Oncol. 2022, 29, 1902-1918.
https://doi.org/10.3390/curroncol29030155
AMA Style
Gouton E, Malissen N, André N, Jeanson A, Pelletier A, Testot-Ferry A, Gaudy-Marqueste C, Dahan L, Tabouret E, Chevalier T,
et al. Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer. Current Oncology. 2022; 29(3):1902-1918.
https://doi.org/10.3390/curroncol29030155
Chicago/Turabian Style
Gouton, Etienne, Nausicaa Malissen, Nicolas André, Arnaud Jeanson, Annick Pelletier, Albane Testot-Ferry, Caroline Gaudy-Marqueste, Laetitia Dahan, Emeline Tabouret, Thomas Chevalier,
and et al. 2022. "Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer" Current Oncology 29, no. 3: 1902-1918.
https://doi.org/10.3390/curroncol29030155
APA Style
Gouton, E., Malissen, N., André, N., Jeanson, A., Pelletier, A., Testot-Ferry, A., Gaudy-Marqueste, C., Dahan, L., Tabouret, E., Chevalier, T., Greillier, L., & Tomasini, P.
(2022). Clinical Impact of High Throughput Sequencing on Liquid Biopsy in Advanced Solid Cancer. Current Oncology, 29(3), 1902-1918.
https://doi.org/10.3390/curroncol29030155
